NewAge Industries Expands Manufacturing Capacity for AdvantaPure Single-Use Tubing and Assemblies

Article

NewAge Industries is adding cleanrooms at its Pennsylvania headquarters.

NewAge Industries, the manufacturer of AdvantaPure high purity tubing products used in single-use systems for biopharmaceutical manufacturing, is expanding capacity at its headquarters facility in southeastern Pennsylvania, according to a July 6, 2021 press release. The project will add more than 3000-ft2 of ISO Class 7 certified cleanrooms to the existing site used to manufacture AdvantaFlex weldable and sealable tubing, AdvantaSil silicone tubing and reinforced hose, and molded single-use tubing assemblies. Anticipated to cost $2 million, the expansion is an extension of a $10 million project completed in 2018.

“We predicted that the expansion we did a few years ago would be all the space we’d need for many years, since it involved over forty-thousand square feet,” said Ken Baker, CEO of NewAge Industries, in the press release. “But no one anticipated the pandemic. Business is robust, and we need more production and assembly rooms. … We’re hiring, we’re improving our processes, and we’re renovating another building that we purchased last year. The additional cleanrooms at our headquarters will help us get more, much-needed product out the door and on the way to our biopharm and pharmaceutical customers.”

The new rooms will be used primarily for the molding and assembly of AdvantaFlex products, including BioClosure container closures, molded tubing connections and assemblies, and tubing sets with various filters, fittings, bottles, and bags. The project is designed and is being constructed by AES Clean Technology of Montgomeryville, Pa., and it is expected to be completed during the third quarter of 2021.

Source: NewAge Industries

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.